Mark J. Ahn

854 total citations
36 papers, 539 citations indexed

About

Mark J. Ahn is a scholar working on Public Health, Environmental and Occupational Health, Accounting and Strategy and Management. According to data from OpenAlex, Mark J. Ahn has authored 36 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 11 papers in Accounting and 9 papers in Strategy and Management. Recurrent topics in Mark J. Ahn's work include Biotechnology and Related Fields (11 papers), Private Equity and Venture Capital (10 papers) and Entrepreneurship Studies and Influences (7 papers). Mark J. Ahn is often cited by papers focused on Biotechnology and Related Fields (11 papers), Private Equity and Venture Capital (10 papers) and Entrepreneurship Studies and Influences (7 papers). Mark J. Ahn collaborates with scholars based in United States, New Zealand and Australia. Mark J. Ahn's co-authors include Ofer Zwikael, Anne S. York, M. Douglas Meeks, Rebecca Bednarek, Brendan Gray, Sally Davenport, Arun Elias, Heidi Schwarzwald, Ashraf Grimwood and Allen Herman and has published in prestigious journals such as International Journal of Project Management, Risk Analysis and Asia Pacific Journal of Management.

In The Last Decade

Mark J. Ahn

33 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark J. Ahn United States 13 208 132 104 72 66 36 539
Anna Chiara Invernizzi Italy 6 188 0.9× 49 0.4× 101 1.0× 121 1.7× 52 0.8× 7 695
Valérie Sabatier France 9 322 1.5× 48 0.4× 121 1.2× 64 0.9× 45 0.7× 14 495
Eugenia Cacciatori United Kingdom 11 334 1.6× 145 1.1× 74 0.7× 77 1.1× 28 0.4× 16 600
Douglas Polley United States 7 303 1.5× 103 0.8× 162 1.6× 70 1.0× 78 1.2× 9 581
Demola Obembe United Kingdom 11 142 0.7× 55 0.4× 72 0.7× 49 0.7× 21 0.3× 41 418
Dimitris Assimakopoulos France 12 287 1.4× 82 0.6× 183 1.8× 82 1.1× 22 0.3× 34 546
John E. Gamble United States 14 334 1.6× 60 0.5× 114 1.1× 111 1.5× 164 2.5× 27 760
Marek Ćwiklicki Poland 13 236 1.1× 27 0.2× 144 1.4× 47 0.7× 25 0.4× 87 561
Francesco Rullani Italy 13 190 0.9× 54 0.4× 104 1.0× 96 1.3× 42 0.6× 48 663
Yasunori Baba Japan 14 352 1.7× 42 0.3× 235 2.3× 198 2.8× 46 0.7× 29 653

Countries citing papers authored by Mark J. Ahn

Since Specialization
Citations

This map shows the geographic impact of Mark J. Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Ahn more than expected).

Fields of papers citing papers by Mark J. Ahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Ahn. The network helps show where Mark J. Ahn may publish in the future.

Co-authorship network of co-authors of Mark J. Ahn

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Ahn. A scholar is included among the top collaborators of Mark J. Ahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Ahn. Mark J. Ahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahn, Mark J. & Amir Shaygan. (2019). Capital Efficiency for Development Stage Biotech-Based Firms: An IPO Perspective. PDXScholar (Portland State University). 1–10. 1 indexed citations
2.
Ahn, Mark J., Amir Shaygan, & Charles M. Weber. (2019). Impact of genomics on biopharmaceutical industry: rare diseases as disruptive innovation. International Journal of Innovation Science. 11(2). 241–260. 2 indexed citations
3.
Ahn, Mark J., et al.. (2015). On valuing biopharmaceutical product pipelines: an effectuation model and evidence. Journal of Innovation and Entrepreneurship. 4(1). 6 indexed citations
4.
Wu, Wei, et al.. (2015). Reverse Stock Splits in the Biotechnology Industry: An Effectuation Approach. Journal of Commercial Biotechnology. 21(1). 4 indexed citations
5.
Ahn, Mark J., et al.. (2013). Creating a framework for the Asian paradigm of hospitality management. PolyU Institutional Research Archive (Hong Kong Polytechnic University). 3 indexed citations
6.
Zwikael, Ofer, Arun Elias, & Mark J. Ahn. (2012). Stakeholder collaboration and engagement in virtual projects. International Journal of Networking and Virtual Organisations. 10(2). 117–117. 11 indexed citations
7.
Dunham, Lee M., Mark J. Ahn, & Anne S. York. (2012). Building a bioeconomy in the heartland. Journal of Enterprising Communities People and Places in the Global Economy. 6(1). 84–100. 6 indexed citations
8.
Ahn, Mark J., et al.. (2012). High technology in emerging markets. Asia-Pacific Journal of Business Administration. 4(1). 23–41. 17 indexed citations
9.
York, Anne S. & Mark J. Ahn. (2011). University technology transfer office success factors: a comparative case study. International Journal of Technology Transfer and Commercialisation. 11(1/2). 26–26. 13 indexed citations
10.
Ahn, Mark J., et al.. (2011). Eye health in New Zealand. Health Education. 111(2). 147–155. 9 indexed citations
11.
Ahn, Mark J., et al.. (2011). Financing development stage biotechnology companies: RMs vs. IPOs.. PubMed. 38(1). 32–54. 1 indexed citations
12.
Zwikael, Ofer & Mark J. Ahn. (2010). The Effectiveness of Risk Management: An Analysis of Project Risk Planning Across Industries and Countries. Risk Analysis. 31(1). 25–37. 143 indexed citations
13.
Ahn, Mark J., et al.. (2010). Pathways to biomedical tipping points: Vertical, horizontal or other?. Journal of Commercial Biotechnology. 16(3). 224–238. 8 indexed citations
14.
Ahn, Mark J., Ofer Zwikael, & Rebecca Bednarek. (2009). Technological Invention to Product Innovation: A Project Management Approach. ANU Open Research (Australian National University). 2 indexed citations
15.
Ahn, Mark J., Ofer Zwikael, & Rebecca Bednarek. (2009). Technological invention to product innovation: A project management approach. International Journal of Project Management. 28(6). 559–568. 22 indexed citations
16.
Ahn, Mark J., M. Douglas Meeks, Sally Davenport, & Rebecca Bednarek. (2009). DEATH OF DISTANCE? — BIOTECHNOLOGY AGGLOMERATION PATTERNS, ALLIANCE PROXIMITY, AND FIRM PERFORMANCE. International Journal of Innovation and Technology Management. 6(3). 247–264. 12 indexed citations
17.
Ahn, Mark J., Ashraf Grimwood, Heidi Schwarzwald, & Allen Herman. (2003). Ethics and the AIDS Pandemic in the Developing World. Journal of the International Association of Physicians in AIDS Care. 2(2). 81–87. 16 indexed citations
18.
Ahn, Mark J.. (2000). Developing a Profitable Market Share Strategy for Multinational Pharmaceutical Companies in China. Journal of Pharmaceutical Marketing & Management. 13(3). 1–29.
19.
Ahn, Mark J.. (2000). Developing a Profitable Market Share Strategy for Multinational Pharmaceutical Companies in China. Journal of Pharmaceutical Marketing & Management. 13(3). 1–30. 1 indexed citations
20.
Ahn, Mark J., et al.. (1991). Strategic risk management : how global corporations manage financial risk for competitive advantage. Medical Entomology and Zoology. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Chiara Invernizzi Breakdown of academic impact, for papers by Valérie Sabatier Breakdown of academic impact, for papers by Eugenia Cacciatori Breakdown of academic impact, for papers by Douglas Polley Breakdown of academic impact, for papers by Demola Obembe Breakdown of academic impact, for papers by Dimitris Assimakopoulos Breakdown of academic impact, for papers by John E. Gamble Breakdown of academic impact, for papers by Marek Ćwiklicki Breakdown of academic impact, for papers by Francesco Rullani Breakdown of academic impact, for papers by Yasunori Baba
Rankless by CCL
2026